Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT01875666 |
| Title | Defining the HER2 Positive (+) Breast Cancer Kinome Response to Trastuzumab, Pertuzumab, Combination Trastuzumab +Pertuzumab, or Combination Trastuzumab + Lapatinib |
| Recruitment | Completed |
| Gender | female |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | UNC Lineberger Comprehensive Cancer Center |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| University of Alabama at Birmingham | Birmingham | Alabama | 35294 | United States | Details | |
| IU Simon Cancer Center | Indianapolis | Indiana | 46202 | United States | Details | |
| Dana Farber Cancer Institute | Boston | Massachusetts | 02215 | United States | Details | |
| Lineberger Comprehensive Cancer Center, UNC | Chapel Hill | North Carolina | 27599 | United States | Details | |
| MD Anderson | Houston | Texas | 77030-4008 | United States | Details |